ORBIMED ADVISORS LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | ORBIMED ADVISORS LLC | 884,230 4.300% | 374,230 (+73.38%) | Filing |
| 2025-02-14 4:22 pm Purchase | 2024-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | ORBIMED ADVISORS LLC | 510,000 8.000% | 510,000 (New Position) | Filing |